TORONTO, November 6, 2024—BenchSci has been recognized by Deloitte’s 2024 Technology Fast 50™ awards program for its rapid growth, entrepreneurial spirit, and bold innovation.
The program recognizes Canada’s 50 fastest-growing technology companies based on the highest revenue growth percentage over the past four years. BenchSci ranks 29 with 743% revenue growth from 2020 to 2023.
Deloitte’s Technology Fast 50 program winners consist of public and private companies in the technology sector that are transforming the industry. The program runs alongside the broader Deloitte North American Technology Fast 500™, and winners are automatically eligible for this elite ranking.
“We’re honored to be recognized for our bold vision for the future of drug discovery and our commitment to leveraging AI to solve some of the biggest challenges in human health,” said Liran Belenzon, CEO and Co-founder of BenchSci. “This award is a reflection of our team’s unwavering dedication to revolutionizing preclinical research and making a real difference in the lives of patients.”
This recognition underscores BenchSci's impact on the life sciences industry. By harnessing the power of AI, its ASCEND platform is transforming preclinical research and development (R&D), serving as an assistant for top scientists at leading pharmaceutical companies and academic institutions. ASCEND's cutting-edge technology decodes and connects the vast landscape of biomedical research and multi-omics data, and integrates it with proprietary customer data. This creates an unbiased map of the underlying biology of disease, empowering scientists to discover novel insights and accelerate R&D.
“These exceptional Technology Fast 50 winners epitomize the spirit of innovation and entrepreneurial excellence in Canada’s technology sector,” expressed Anders McKenzie, the National Technology Fast 50 program leader at Deloitte Canada. “By demonstrating remarkable growth rates and showcasing their ability to adapt and thrive in a rapidly evolving market, these companies have distinguished themselves as leaders in their respective fields. Their success not only reflects their own ingenuity and dedication but also contributes to the overall growth and competitiveness of Canada’s technology ecosystem. We are proud to celebrate their achievements and recognize them as the driving force behind the country’s technological advancement and economic prosperity.”
To qualify for the Deloitte Technology Fast 50 ranking, companies must have been in business for at least four years, have a minimum revenue of $50,000 in 2020 and $5 million in 2023, be headquartered in Canada, own proprietary technology, and invest a minimum of 5% of gross revenues in R&D activities that are conducted in Canada.
About BenchSci
BenchSci is a world leader in AI solutions for drug discovery on a mission to exponentially increase the speed and quality of life-saving R&D to help bring new medicines to patients faster. We apply AI to understand how disease biology works throughout the drug discovery pipeline to solve the number one reason drug discovery projects fail—getting the biology wrong. Our platform, ASCEND, acts as a scalable AI assistant for preclinical organizations, increasing the productivity of the preclinical R&D pipeline across therapeutic areas. Backed by top-tier investors, including Generation Investment Management, iNovia Capital, TCV, F-Prime, Gradient Ventures (Google’s AI fund), and Golden Ventures, BenchSci has raised over $200 million. Our platform accelerates science at 16 top-20 pharmaceutical companies and over 4,500 leading research centers worldwide. We’re a Deloitte Technology Fast 50™ and Fast 500™ winner and a certified Great Place to Work®. For more information about BenchSci, visit www.benchsci.com.
About the Deloitte Technology Fast 50 program
The Deloitte Technology Fast 50 program is Canada’s pre-eminent technology awards program. It recognizes business growth, innovation, and entrepreneurship in four distinct categories: Technology Fast 50, Enterprise–Industry Leaders, Clean Technology, and Companies-to-Watch. The program also recognizes thriving technology companies in the United States and Canada in partnership with the North American Technology Fast 500 program. Program sponsors for 2024 include RBCx, Osler, EDC, CCI, TMX, Clarity, and Lafond. For more information, visit www.fast50.ca.
For more information, please contact Christina Peck at cpeck@benchsci.com.
